• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Thyroid Cancer

  • The CancerConnect Thyroid Cancer Newsletter
    February 2, 2019

    The CancerConnect Thyroid Cancer Newsletter

    Charles H. Weaver, MD
  • It’s National Thyroid Awareness Month
    January 1, 2019

    It’s National Thyroid Awareness Month

    Charles H. Weaver, MD
  • Caprelsa Delays Progression of Advanced Medullary Thyroid Cancer
    December 8, 2018

    Caprelsa Delays Progression of Advanced Medullary Thyroid Cancer

    Charles H. Weaver, MD
  • Larotrectinib Demonstrates High Response Rate in TRK Thyroid Cancers
    August 17, 2018

    Larotrectinib Demonstrates High Response Rate in TRK Thyroid Cancers

    Charles H. Weaver, MD
  • FDA Approves Tafinlar plus Mekinst for Patients With Anaplastic Thyroid Cancer
    August 2, 2018

    FDA Approves Tafinlar plus Mekinst for Patients With Anaplastic Thyroid Cancer

    Charles H. Weaver, MD
  • BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer
    July 26, 2018

    BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer

    Charles H. Weaver, MD
  • Use of Radioactive Iodine for Thyroid Cancer Has Increased
    July 25, 2018

    Use of Radioactive Iodine for Thyroid Cancer Has Increased

    Charles H. Weaver, MD
  • Gene Expression Test Identifies Low-Risk Thyroid Nodules
    July 19, 2018

    Gene Expression Test Identifies Low-Risk Thyroid Nodules

    Charles H. Weaver, MD
  • Therapies Show Initial Effectiveness in Subset of Papillary Thyroid Cancer
    July 18, 2018

    Therapies Show Initial Effectiveness in Subset of Papillary Thyroid Cancer

    Charles H. Weaver, MD
  • TSH Suppression after Thyroidectomy May Not Be Beneficial
    July 18, 2018

    TSH Suppression after Thyroidectomy May Not Be Beneficial

    Charles H. Weaver, MD
  • Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer
    July 17, 2018

    Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer

    Charles H. Weaver, MD
  • Nexavar Approved for Metastatic Differentiated Thyroid Cancer
    July 13, 2018

    Nexavar Approved for Metastatic Differentiated Thyroid Cancer

    Charles H. Weaver, MD
Previous Page
1 2 3 4 5
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...